M D Yahr, R C Duvoisin, M J Schear, R E Barrett, M M Hoehn. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedAnorexia Nervosa/chemically inducedArrhythmias, Cardiac/chemically inducedDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/therapeutic useFemaleGait/drug effectsHumansHypotension/chemically inducedMaleMiddle AgedMovement Disorders/chemically inducedNausea/chemically inducedParkinson Disease/drug therapyParkinson Disease, Postencephalitic/drug therapyPhenylacetates/cerebrospinal fluidSpeech Disorders/drug therapyTremor/drug therapyVomiting/chemically induced
Substances: See more » PhenylacetatesDihydroxyphenylalanine
Year: 1969 PMID: 5820999 DOI: 10.1001/archneur.1969.00480160015001
Source DB: PubMed Journal: Arch Neurol ISSN: 0003-9942